Molecular Pathology

Janus Kinase 2 (Jak-2) Mutation Leukemia Diagnosis Test

Got Questions?
Give us a call today at

The (Janus Kinase 2) JAK-2 gene mutation plays a critical role in guiding cells to produce the JAK2 protein, which is essential for promoting cell growth, division, and the regulation of blood cell production in the bone marrow. This protein is key to maintaining the proper balance of blood cell formation, ensuring healthy blood cell turnover.

 

The JAK2 test aims to detect mutations in the gene that associates with bone marrow disorders, specifically myeloproliferative neoplasms (MPNs). These disorders characterize through the overproduction of blood cells, leading to a range of clinical conditions. Identifying JAK2 mutations is crucial for diagnosing and managing MPNs, as these genetic alterations are often the driving factor behind the abnormal proliferation of blood cells in the bone marrow.

 

Some of the MPNs which links to JAK2 mutations are:

  • Polycythemia vera (PV) – The bone marrow produces too many red blood cells.
  • Essential thrombocythemia (ET) – Excess platelet-producing cells in the bone marrow.
  • Primary myelofibrosis (PMF) – This is also known as agnogenic myeloid metaplasia. Overproduction of scar tissue-producing and platelet-producing cells in the bone marrow.

 

Why Take The Jak-2 Test For Leukemia?

  • Early Detection and Diagnosis: Taking the test and diagnosing leukemia and other disorders related to blood early allows for early intervention, boosting the patient’s chances of recovery.
  • Treatment Decisions: The test results will guide the kind of treatment that the patient will take.
  • Disease Progression Monitoring: The test gives the patient an idea about the progression of their disease.
  • Therapy Response Review: The test reviews how well the patient’s body responds to treatment and therapy for their disease.

 

 

 

JAK2 mutation testing is typically recommended for individuals who show signs or symptoms of certain myeloproliferative neoplasms (MPNs) or related blood disorders. It is particularly advised for:

 

  1. Patients with elevated blood cell counts:
  • Elevated red blood cells (erythrocytosis): Suggestive of polycythemia vera (PV).
  • Elevated platelets (thrombocytosis): Associated with essential thrombocythemia (ET).
  • Elevated white blood cells (leukocytosis): May point to primary myelofibrosis (PMF) or other MPNs.
  1. Unexplained splenomegaly (enlarged spleen):
  • An enlarged spleen is common in MPNs and may warrant JAK2 testing to identify an underlying blood disorder.
  1. Patients with abnormal blood clotting or bleeding:
  • Thrombosis (blood clots) or abnormal bleeding, especially in unusual locations (like the abdominal veins), can indicate an MPN, which often involves JAK2 mutations.
  1. Unexplained fatigue, night sweats, or weight loss:
  • These systemic symptoms often associates with MPNs and should be for further evaluation with JAK2 testing if other signs of MPNs are present.
  1. Patients with a diagnosis of an MPN:
  • Individuals who are already diagnosed with an MPN such as polycythemia vera, essential thrombocythemia, or primary myelofibrosis may undergo JAK2 testing for diagnostic confirmation and treatment planning.
  1. Those with family history of myeloproliferative neoplasms:
  • Although MPNs are typically not inherited, a family history may prompt testing if symptoms or abnormal blood counts are present.

 

In summary, JAK2 mutation testing is crucial for diagnosing and managing MPNs, particularly in individuals with unexplained changes in blood cell counts, systemic symptoms, or blood clotting abnormalities.

FAQs

What is a JAK2 blood test for?

JAK2 Blood Test helps diagnose bone marrow disorders.

 

What does it mean if you are JAK2 positive?

If you are positive in the test, then you have a strong chance of having a myeloproliferative neoplasm (MPN), which is a roup of conditions that affect the bone marrow. An MPN also leads to the overproduction of blood cells.

 

What diseases are associated with JAK2?

The diseases associated with JAK2 are polycythemia vera, essential thrombocythemia, and primary myelofibrosis. These are myeloproliferative neoplasms (MPNs), caused by excess blood production. However, these MPNs are also linked to blood cancers.

 

Book Your Jak-2 Gene Mutation Test With MediLinx

For timely results and accuracy, book your Jak-2 test today and our medical procedures, such as Complete Blood Count (CBC) with Medi Linx Laboratory via our Virtual Lab! Contact us at 0939-9227341, or visit our QC Lab on the 2nd floor of Avire Tower P. Tuazon Blvd. Project 4, Quezon City!

Got Questions?
Give us a call today at

We Would Love To Hear Your Feedback

Share us your thoughts through this survey

What We Do

Lab to Lab (Send-Out Laboratory Services)

Lab to Lab (Send-Out Laboratory Services)

Hospitals and clinics are given access to QUALITY laboratory services that are unavailable to them through our Send-Out Laboratory Service. Clinical Chemistry...

Specimen Transport Support Service

Specimen Transport Support Service

Specimen Transport Support Service is Medi Linx’s pick-up and transport of laboratory specimen where our partners are guaranteed with the highest quality and...

To know more about our wide array of routine and specialized clinical tests,

Contact Us!

Homepage Contact Us

"*" indicates required fields

A proud member of

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.